The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated with Neoadjuvant Chemotherapy

Programmed death ligand 1 (PD-L1) is an inhibitory molecule expressed by cancer cells to supress T-cell activity and escape anti-tumour immunity. The role of PD-L1 in cancer has been studied extensively as it is considered an important immune checkpoint against immune over-activation through its int...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Dughaishi, Malika, Shalaby, Asem, Al-Ribkhi, Khawla, Boudaka, Ammar, Boulassel, Mohamed-Rachid, Saleh, Jumana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930029/
https://www.ncbi.nlm.nih.gov/pubmed/31897310
http://dx.doi.org/10.18295/squmj.2019.19.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930029/
https://www.ncbi.nlm.nih.gov/pubmed/31897310
http://dx.doi.org/10.18295/squmj.2019.19.04.002

Ejemplares similares